Colleen Tupper
President at DYAX CORP.
Net worth: 2 M $ as of 2024-03-30
Profile
Colleen Tupper is currently the President, Treasurer & Director at Dyax Corp.
and Shire US, Inc. She is also the Chief Financial Officer at BioDelivery Sciences International, Inc. and Collegium Pharmaceutical, Inc. In the past, she served as the Co-President at Baxalta, Inc. and as the Senior Vice President & CFO-US Business Unit at Takeda Pharmaceuticals U.S.A., Inc. Ms. Tupper completed her undergraduate degree at Franklin Pierce University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-26 | 39,421 ( 0.12% ) | 2 M $ | 2024-03-30 |
Colleen Tupper active positions
| Companies | Position | Start |
|---|---|---|
| DYAX CORP. | President | - |
| COLLEGIUM PHARMACEUTICAL, INC. | Director of Finance/CFO | 2021-05-23 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Director of Finance/CFO | 2022-03-21 |
Shire US, Inc.
 Shire US, Inc. Medical DistributorsDistribution Services Shire US, Inc. sells and markets prescription medicines. The company was founded on September 28, 1983 and is headquartered in Lexington, MA. | President | - |
Former positions of Colleen Tupper
| Companies | Position | End |
|---|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | 2021-03-31 |
| BAXALTA INC | President | - |
Training of Colleen Tupper
| Franklin Pierce University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Dyax Corp.
 Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
Baxalta, Inc.
 Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
Shire US, Inc.
Shire US, Inc. Medical DistributorsDistribution Services Shire US, Inc. sells and markets prescription medicines. The company was founded on September 28, 1983 and is headquartered in Lexington, MA. | Distribution Services |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Health Technology |
- Stock Market
- Insiders
- Colleen Tupper
